Oberweis Asset Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
Oberweis Asset Management's LMAT Position: Q3 2026 in Review
Oberweis Asset Management sold out of LeMaitre Vascular (LMAT) in Q3 2026, closing a stake of 158,502 shares — an estimated $15.2M sold.
Oberweis Asset Management first reported a position in LMAT in Q3 2022 and held it in 16 quarters. The position peaked at $16.2M in Q1 2026. 298 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.
- Oberweis Asset Management reported no remaining LeMaitre Vascular position as of Q3 2026 after selling out during the quarter.
- Oberweis Asset Management sold 158,502 LeMaitre Vascular shares in Q3 2026, an estimated $15.2M.
- Oberweis Asset Management first reported a position in LeMaitre Vascular in Q3 2022 and held it in 16 quarters.
- Oberweis Asset Management's LeMaitre Vascular position peaked at $16.2M in Q1 2026.
- 298 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.
Based on Oberweis Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.